ESPN reports:
"Performance Analytics," an MIT Sloan Sports Analytics Conference panel
of John Brenkus, Mike McCann, Kevin Pritchard, Angela Ruggiero, Mark
Verstegen, and moderator Peter Keating, says that while our
understanding of the athletic body is fast-progressing, there are, and
will continue to be, hurdles.
The issues, surprisingly, are more scientific than moral.
The central conflict comes between a player’s right to privacy and
the team’s imperative to get as much actionable information about them
as possible. Genetic testing that identifies predispositions to, say,
ACL tears or inflammatory conditions, could help the team better
identify risks and help the player avoid them. But it would also leave
players at a disadvantage in contract negotiations and draft
positioning.
Genetic testing also can create some red herrings. Brenkus pointed out
that predisposition to a condition and actually having a condition are
two different categories: Someone with a predisposition to ACL issues
might have trained and strengthened their ligament to the point that the
predisposition was mitigated or completely wiped out. In this case a
monomaniacal focus on genetic markers can lead a team astray.
Click here to continue reading.
No comments:
Post a Comment